Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).

Breast-conserving surgery is commonly performed to remove early-stage breast cancer or ductal carcinoma in situ (DCIS). During surgery, the goal is to completely remove the tumour with a clear margin of normal tissue around it. If cancer cells are found at the edge of the removed tissue (a "positive margin"), patients may need a second operation (re-excision). Re-excision can delay further treatment, increase patient anxiety, and increase healthcare costs. To help assess margins during surgery, surgeons use specimen imaging. Standard practice involves two-dimensional (2D) specimen mammography

Trial Details

NCT ID
NCT07426809
Phase
NA
Sponsor
Royal College of Surgeons, Ireland
Status
RECRUITING
Cancer Type
Ductal Carcinoma In Situ (DCIS) Breast Cancer
Interventions
  • Standard 2D Specimen Mammography
  • Mozart 3D Specimen Radiography System
Locations (sample)
  • Beaumont, Dublin, Ireland|53.38721,-6.22713

Key Eligibility Criteria

  • Female patients
  • Age ≥ 18 years
  • Diagnosis of primary invasive breast cancer or ductal carcinoma in situ (DCIS)
  • Planned breast-conserving surgery with curative intent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ductal Carcinoma In Situ (DCIS) Breast Cancer Trials on Trialify →